Compare Erasca Inc. Common Stock (ERAS) vs NICE Ltd (NICE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Erasca Inc. Common Stock vs NICE Ltd — how do they compare? Erasca Inc. Common Stock trades at $15.37 (market cap $5.40B), while NICE Ltd trades at $117 (market cap $6.81B). The key difference: NICE Ltd is the larger of the two by market cap, and NICE Ltd is more actively traded (382,395 versus 9,533,185). Which is the better fit depends on your goals — on Pluang, investors hold Erasca Inc. Common Stock for 0 Days and NICE Ltd for 15 Days on average.
| ERAS | NICE | |
|---|---|---|
Market Cap | $5.40B | $6.81B |
Volume | 9,533,185 | 382,395 |
Sector | Health | Technology |
52-Week High | $22.47 | $137.68 |
52-Week Low | $2.20 | $83.15 |
Typical Hold Time | 0 Days | 15 Days |
Enterprise Value | $5.18B | $6.54B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NICE Ltd. (NICE) trades at $116.42, up 0.95% on the day, with a bullish technical signal from moving averages. The company shows solid fundamentals with a P/E of 17.08 and strong profitability margins, including a 65.12% gross margin. Recent earnings have consistently beaten expectations, and analyst consensus is bullish with a $124.20 price target. Business developments include being named a leader in IDC MarketScape for contact center platforms, highlighting its competitive position in AI-driven customer experience solutions.
The outlook for NICE is positive, supported by AI-driven growth and a reasonable valuation. Investment opportunities include continued cloud and AI revenue expansion, while risks involve margin compression from heavy investment and market volatility. With no sell ratings from analysts and institutional buying activity, the stock presents a favorable risk-reward profile for growth-oriented investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Erasca Inc. Common Stock
Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.
Read more on ERAS →About NICE Ltd
NICE Ltd. is a global leader in both enterprise software and cloud computing, specializing in customer experience and financial crime prevention solutions. The company's platform utilizes advanced analytics, AI, and automation to help organizations enhance customer interactions, ensure compliance, and combat fraud. NICE serves a diverse client base, including contact centers, financial institutions, and government agencies, by optimizing operations and improving service quality.
Read more on NICE →
